Fosaprepitant Dimeglumine/Palonosetron Hydrochloride

福沙吡坦二甲葡胺/盐酸帕洛诺司琼

Report date: 2023/05/29 10:50:48

Base Information

Drug NameFosaprepitant Dimeglumine/Palonosetron Hydrochloride
Drug Alias NameBH006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsNeurokinin 1 receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Fosaprepitant DimegluminePalonosetron Hydrochloride
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhuhai Beihai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Beihai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A